Skip to content

Total Shoulder Arthroplasty Near-infrared Spectroscopy

The Effects of Positive-pressure Ventilation on Cerebral Oxygenation and Cardiac Output in Total Shoulder Arthroplasty.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02198183
Acronym
TSA NIRS
Enrollment
34
Registered
2014-07-23
Start date
2014-07-31
Completion date
2015-10-31
Last updated
2023-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Ischemia

Brief summary

The purpose of this study is to measure cerebral oxygenation and cardiac output of total shoulder replacement patients undergoing general anesthesia (GA) and positive-pressure ventilation (PPV). We hypothesize that cerebral desaturation occurs frequently during GA with PPV, but is rare during GA and spontaneous ventilation. We also hypothesize that cardiac output usually is well maintained under GA in the sitting position when epinephrine is used, but that decreased cardiac output increases the risk of cerebral desaturation.

Interventions

DEVICECasmed Fore-Sight Elite
DEVICENon-invasive Cardiac Output Monitor (NICOM)

Sponsors

Hospital for Special Surgery, New York
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients 18-99 undergoing total shoulder arthroplasty * Planned general anesthesia + brachial plexus nerve block * Planned arterial catheter

Exclusion criteria

* Patients younger than 18 years older and older than 99 * Patients not intending to receive general anesthesia and peripheral nerve block * Indication for endotracheal tube * BMI ≥ 30 * Ejection Fraction (if known) \< 50% * Known significant restrictive or obstructive pulmonary disease * Patients with a history of transient ischemic attack (TIA) or stroke * Patients with recent signs or symptoms of myocardial ischemia * Current stress test positive for ischemia * Intolerance to study medications * pre-existing contraindication to regional anesthesia * infection at block site * pre-existing neurological injury to operative limb * Non-English speaking patients

Design outcomes

Primary

MeasureTime frameDescription
Number of Cerebral Desaturation EventsDay of surgeryThe number of Cerebral Desaturation Events (CDE) that occured. CDE is defined as a reduction in cerebral tissue oxygen saturation of \>20% from baseline that lasts for 90 seconds or longer.

Secondary

MeasureTime frameDescription
Cardiac Output (CO)Day of surgeryCardiac output of patients as measured in liters per minute
Cardiac Index (CI)Day of surgeryAverage cardiac index for patients, a measurement of how efficient the heart is pumping. Measured in liters per minute per meters squared of heart size.
Stroke Volume (SV)Day of surgeryStroke volume, the amount of blood pumped by the left ventricle of the heart with each contraction. Measured in milliliters.
Mean Arterial Pressure (MAP)Day of surgerymean arterial pressure and noninvasive blood pressure will be represented as a percentage of baseline after surgery. A lower percentage is a worse outcome.
End Tidal Carbon Dioxide (ETCO2)Day of surgerya lower score is a better outcome.
Intravenous Fluid VolumeDay of surgery

Countries

United States

Participant flow

Participants by arm

ArmCount
Near-infrared Spectroscopy
Casmed Fore-Sight Elite and Non-invasive Cardiac Output Monitor (NICOM) Casmed Fore-Sight Elite Non-invasive Cardiac Output Monitor (NICOM)
25
Total25

Baseline characteristics

CharacteristicNear-infrared Spectroscopy
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
17 Participants
Age, Categorical
Between 18 and 65 years
8 Participants
Age, Continuous67 years
STANDARD_DEVIATION 8
Region of Enrollment
United States
25 participants
Sex: Female, Male
Female
11 Participants
Sex: Female, Male
Male
14 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 25
other
Total, other adverse events
0 / 25
serious
Total, serious adverse events
0 / 25

Outcome results

Primary

Number of Cerebral Desaturation Events

The number of Cerebral Desaturation Events (CDE) that occured. CDE is defined as a reduction in cerebral tissue oxygen saturation of \>20% from baseline that lasts for 90 seconds or longer.

Time frame: Day of surgery

ArmMeasureValue (NUMBER)
Near-infrared SpectroscopyNumber of Cerebral Desaturation Events0 Number of CDE Incidences
Secondary

Cardiac Index (CI)

Average cardiac index for patients, a measurement of how efficient the heart is pumping. Measured in liters per minute per meters squared of heart size.

Time frame: Day of surgery

ArmMeasureValue (MEAN)Dispersion
Near-infrared SpectroscopyCardiac Index (CI)3 L/min/m^2Standard Deviation 0.5
Secondary

Cardiac Output (CO)

Cardiac output of patients as measured in liters per minute

Time frame: Day of surgery

ArmMeasureValue (MEAN)Dispersion
Near-infrared SpectroscopyCardiac Output (CO)5.6 liters per minuteStandard Deviation 1.2
Secondary

End Tidal Carbon Dioxide (ETCO2)

a lower score is a better outcome.

Time frame: Day of surgery

ArmMeasureGroupValue (MEAN)Dispersion
Near-infrared SpectroscopyEnd Tidal Carbon Dioxide (ETCO2)GA without PPV44 mmHgStandard Deviation 5
Near-infrared SpectroscopyEnd Tidal Carbon Dioxide (ETCO2)GA with PPV45 mmHgStandard Deviation 6
Secondary

Intravenous Fluid Volume

Time frame: Day of surgery

ArmMeasureValue (MEAN)Dispersion
Near-infrared SpectroscopyIntravenous Fluid Volume1408 mLStandard Deviation 227
Secondary

Mean Arterial Pressure (MAP)

mean arterial pressure and noninvasive blood pressure will be represented as a percentage of baseline after surgery. A lower percentage is a worse outcome.

Time frame: Day of surgery

ArmMeasureGroupValue (MEAN)Dispersion
Near-infrared SpectroscopyMean Arterial Pressure (MAP)GA without PPV76 percentStandard Deviation 15
Near-infrared SpectroscopyMean Arterial Pressure (MAP)GA with PPV67 percentStandard Deviation 17
Secondary

Stroke Volume (SV)

Stroke volume, the amount of blood pumped by the left ventricle of the heart with each contraction. Measured in milliliters.

Time frame: Day of surgery

ArmMeasureValue (MEAN)Dispersion
Near-infrared SpectroscopyStroke Volume (SV)74 millilitersStandard Deviation 11

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026